chr12-6867505-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBS1_SupportingBS2
The NM_001159287.1(TPI1):āc.50T>Gā(p.Ile17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,579,330 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0038 ( 2 hom., cov: 34)
Exomes š: 0.0029 ( 11 hom. )
Consequence
TPI1
NM_001159287.1 missense
NM_001159287.1 missense
Scores
3
13
Clinical Significance
Conservation
PhyloP100: 2.12
Genes affected
TPI1 (HGNC:12009): (triosephosphate isomerase 1) This gene encodes an enzyme, consisting of two identical proteins, which catalyzes the isomerization of glyceraldehydes 3-phosphate (G3P) and dihydroxy-acetone phosphate (DHAP) in glycolysis and gluconeogenesis. Mutations in this gene are associated with triosephosphate isomerase deficiency. Pseudogenes have been identified on chromosomes 1, 4, 6 and 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
PM1
In a chain Triosephosphate isomerase (size 247) in uniprot entity TPIS_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_001159287.1
BP4
Computational evidence support a benign effect (MetaRNN=0.008082598).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00377 (573/152082) while in subpopulation AFR AF= 0.00755 (313/41482). AF 95% confidence interval is 0.00686. There are 2 homozygotes in gnomad4. There are 269 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPI1 | NM_001159287.1 | c.50T>G | p.Ile17Arg | missense_variant | 1/7 | NP_001152759.1 | ||
TPI1 | NM_000365.6 | c.-62T>G | upstream_gene_variant | ENST00000396705.10 | NP_000356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPI1 | ENST00000229270.8 | c.50T>G | p.Ile17Arg | missense_variant | 1/7 | 1 | ENSP00000229270.4 | |||
TPI1 | ENST00000613953.4 | c.50T>G | p.Ile17Arg | missense_variant | 1/7 | 1 | ENSP00000484435.1 | |||
TPI1 | ENST00000396705.10 | c.-62T>G | upstream_gene_variant | 1 | NM_000365.6 | ENSP00000379933.4 |
Frequencies
GnomAD3 genomes AF: 0.00379 AC: 576AN: 151968Hom.: 2 Cov.: 34
GnomAD3 genomes
AF:
AC:
576
AN:
151968
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00210 AC: 405AN: 193188Hom.: 0 AF XY: 0.00218 AC XY: 230AN XY: 105348
GnomAD3 exomes
AF:
AC:
405
AN:
193188
Hom.:
AF XY:
AC XY:
230
AN XY:
105348
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00291 AC: 4160AN: 1427248Hom.: 11 Cov.: 34 AF XY: 0.00299 AC XY: 2111AN XY: 707182
GnomAD4 exome
AF:
AC:
4160
AN:
1427248
Hom.:
Cov.:
34
AF XY:
AC XY:
2111
AN XY:
707182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00377 AC: 573AN: 152082Hom.: 2 Cov.: 34 AF XY: 0.00362 AC XY: 269AN XY: 74342
GnomAD4 genome
AF:
AC:
573
AN:
152082
Hom.:
Cov.:
34
AF XY:
AC XY:
269
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
3
ExAC
AF:
AC:
262
Asia WGS
AF:
AC:
9
AN:
3474
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 18, 2022 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | TPI1: BP4, BS2 - |
Triosephosphate isomerase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 10, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at